Traws Pharma, Inc. — Director's Dealing 2015

Jun 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2015-06-15

Reporting Person: Hoffman Michael B (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-15	Stock Option (right to purchase)	$2.69	A	13000	Acquired	2025-06-15	Common Stock (13000)	Direct

Footnotes

F1: These options vest over one year in 12 equal monthly installments.